Ultralife Co. (NASDAQ:ULBI) Shares Sold by Bailard Inc.

Bailard Inc. cut its holdings in shares of Ultralife Co. (NASDAQ:ULBI) by 29.9% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 19,131 shares of the technology company’s stock after selling 8,166 shares during the period. Bailard Inc.’s holdings in Ultralife were worth $203,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the business. Empowered Funds LLC lifted its stake in Ultralife by 7.8% during the first quarter. Empowered Funds LLC now owns 31,396 shares of the technology company’s stock valued at $277,000 after purchasing an additional 2,275 shares during the last quarter. Perritt Capital Management Inc. raised its holdings in shares of Ultralife by 25.0% during the first quarter. Perritt Capital Management Inc. now owns 15,000 shares of the technology company’s stock valued at $132,000 after acquiring an additional 3,000 shares during the period. Vanguard Group Inc. raised its holdings in shares of Ultralife by 1.3% during the first quarter. Vanguard Group Inc. now owns 515,840 shares of the technology company’s stock valued at $4,545,000 after acquiring an additional 6,640 shares during the period. Victory Capital Management Inc. acquired a new stake in shares of Ultralife during the fourth quarter valued at approximately $59,000. Finally, Visionary Wealth Advisors raised its holdings in shares of Ultralife by 0.9% during the fourth quarter. Visionary Wealth Advisors now owns 1,082,246 shares of the technology company’s stock valued at $7,381,000 after acquiring an additional 9,997 shares during the period. 30.68% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

ULBI has been the topic of a number of recent analyst reports. Benchmark boosted their price target on shares of Ultralife from $13.00 to $14.00 and gave the company a “buy” rating in a report on Thursday, June 27th. StockNews.com upgraded shares of Ultralife from a “buy” rating to a “strong-buy” rating in a report on Monday, August 12th.

Ultralife Stock Down 3.0 %

Ultralife stock opened at $10.55 on Wednesday. The firm has a market cap of $175.34 million, a PE ratio of 16.48 and a beta of 0.99. The company has a debt-to-equity ratio of 0.07, a quick ratio of 2.06 and a current ratio of 4.07. The firm’s 50 day moving average price is $10.64 and its two-hundred day moving average price is $10.29. Ultralife Co. has a twelve month low of $6.36 and a twelve month high of $13.39.

Ultralife (NASDAQ:ULBI) last released its quarterly earnings data on Thursday, July 25th. The technology company reported $0.22 earnings per share for the quarter, beating the consensus estimate of $0.14 by $0.08. The firm had revenue of $42.98 million for the quarter. Ultralife had a net margin of 5.96% and a return on equity of 9.32%.

About Ultralife

Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium-ion cells, multi-kilowatt module lithium-ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables.